Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Feb 22, 2022Company is No. 1 Best Large Employer in Health Care Equipment & Services Industry
FRANKLIN LAKES, N.J., Feb. 22, 2022 -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that it ranked No. 1 in the Health Care Equipment &...
-
Feb 8, 2022Organizations including Superhuman Use BD Veritor™ At-Home COVID-19 Test with the ReturnSafe Platform to Keep Employees Safe at Work
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration with ReturnSafe, the all-in-one software solution for COVID-19 employee...
-
Feb 3, 2022- Revenue of $5.0 billion declined 6.0% as reported and 5.9% on currency-neutral basis, due to a decline in worldwide COVID-only testing revenues to $185 million from $866 million in the prior year
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its first quarter of fiscal year 2022, which ended December 31, 2021. "Our...
-
Feb 1, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of directors has approved the planned spinoff of its diabetes care business,...
-
Feb 1, 2022Informatics Capabilities Help Expand BD Data Analytics Capabilities and Understanding of Cancer and Other Chronic Diseases
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of Cytognos, a privately held company headquartered in...
-
Jan 27, 2022Company Included in 2022 Bloomberg Gender-Equality Index and Named Best Place to Work for LGBTQ+ Equality from The Human Rights Campaign Foundation
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been included in the 2022 Bloomberg Gender-Equality Index (GEI) for the...
-
Jan 26, 2022Study uses real-world data to demonstrate the effectiveness of vaginal panel performed on the BD MAX™ System compared to clinicians' assessments
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the outcome of a peer-reviewed study published in the journal of Obstetrics &...
-
Jan 25, 2022
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.87 per common share, payable on March 31, 2022 to holders of record on March 10,...
-
Jan 20, 2022Technology Breakthrough Has Potential to Transform Wide Range of Disciplines from Immunology and Genomics Research to Cell-Based Therapeutics
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that a study conducted in collaboration with the European Molecular Biology Laboratory...
-
Jan 11, 2022JUST 100, the Only Ranking that Recognizes Companies Doing Right by All Their Stakeholders as Defined by the American Public, Acknowledges BD's Commitment to Environmental, Social and Governance Performance
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it was named to the JUST 100 list of America's most just companies by JUST Capital and...
-
Jan 11, 2022Joint Effort Will Highlight How Diagnostic Best Practices Can Improve Patient Care, Clinical Practice and Health Care Economics
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration with Pfizer Inc. and global charitable foundation Wellcome to better...
-
Jan 7, 2022BD Kiestra™ IdentifA Receives 510(K) Clearance for Automated Sample Processing and MALDI Target Preparation
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)...
-
Jan 6, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that in the interest of the health and safety of its shareholders, directors, officers,...
-
Jan 6, 2022Highlights Company's Impact on Advancing Cybersecurity Maturity in Health Care
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released its second annual cybersecurity report to update stakeholders on the state of health...
-
Jan 5, 2022
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report financial results for its first quarter of fiscal year 2022 on Thursday, Feb. 3, 2022. A news release will be...
-
Dec 22, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will virtually present at the 40th Annual J.P. Morgan Healthcare Conference via...
-
Dec 22, 2021Tests now available online through Everly Health and in-store at Winn-Dixie, Harveys Supermarket, and Fresco y Más
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical company, today announced the BD Veritor™ At-Home COVID-19 Test is now available for purchase through Everly Health, a...
-
Dec 21, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Embecta Corp. ("embecta"), the independent, publicly-traded company that will hold...
-
Dec 21, 2021Advances company's innovation focus on enabling new care settings and accelerating smart connected care
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of privately held Scanwell Health Inc., a leader in...
-
Dec 17, 2021BD COR™ MX for Infectious Disease Testing Receives CE Mark and is Final Instrument Introduced on BD COR™ System
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has expanded the BD COR™ System to include a new MX instrument for high-throughput...
-
Dec 15, 2021€70 Million Investment to Establish New Research Laboratories, Jobs in Software Engineering, Informatics and Cybersecurity
LIMERICK, IRELAND (15TH Dec. 2021) –BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to create more than 130 new jobs and invest €
-
Dec 9, 2021
Stamford, Conn. – Dec. 9, 2021 – The global medical technology company, BD (Becton, Dickinson and Company), has committed $500,000 to improve quality of care and reduce health inequities for...
-
Dec 9, 2021- Acquisition complements BD's core portfolio - adding an innovative, broadly applicable surgical sealant to a suite of BD biosurgery products already relied upon in the operating room.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Tissuemed, Ltd., a privately held firm headquartered in Leeds, England...
-
Dec 8, 2021Addition of 100 local jobs will play key role in bolstering manufacturing capacity to supply the market with pre-filled flush syringes for use in health care settings
DROGHEDA, IRELAND (December 8, 2021) – BD (Becton Dickinson and Company), a leading global medical technology company, held a ribbon cutting ceremony today to announce the creation of 100 new...
-
Dec 6, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that "embecta" [pronounced em-BECK-tah] will be the name of the independent,...